SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368,579 | -54.1% | 13,364 | -50.4% | 0.00% | -100.0% |
| Q2 2023 | $803,472 | +7.1% | 26,917 | +31.2% | 0.00% | 0.0% |
| Q1 2023 | $750,534 | -22.8% | 20,512 | -24.9% | 0.00% | 0.0% |
| Q4 2022 | $972,670 | +23.0% | 27,330 | +17.8% | 0.00% | 0.0% |
| Q3 2022 | $791,000 | +54.5% | 23,196 | +29.9% | 0.00% | 0.0% |
| Q2 2022 | $512,000 | -6.9% | 17,852 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $550,000 | +128.2% | 16,991 | +119.0% | 0.00% | – |
| Q2 2021 | $241,000 | -24.2% | 7,758 | -48.7% | 0.00% | -100.0% |
| Q3 2020 | $318,000 | -86.5% | 15,111 | -70.7% | 0.00% | -75.0% |
| Q1 2018 | $2,363,000 | +1058.3% | 51,590 | +538.4% | 0.00% | – |
| Q4 2016 | $204,000 | – | 8,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |